Table 4.
CAROC | Canadian FRAX
|
|||
---|---|---|---|---|
Low (<10%) | Moderate (10–20%) | High (>20%) | Total | |
All subjects | ||||
Low (<10%) | 20,857 (53) | 889 (2) | 0 (0) | 21,746 (55) |
Moderate (10–20%) | 2,028 (30) | 9,894 (25) | 364 (1) | 12,286 (31) |
High (>20%) | 5 (0) | 1,497 (4) | 4,069 (10) | 5,571 (14) |
Total | 22,890 (342) | 12,280 (31) | 4,433 (11) | 39,603 (100) |
Concordance | 34,820 (88) | |||
No-risk factors | ||||
Low (<10%) | 20,857 (65) | 889 (3) | 0 (0) | 21,746 (67) |
Moderate (10–20%) | 704 (12) | 7,684 (24) | 306 (1) | 8,694 (27) |
High (>20%) | 0 (0) | 350 (1) | 1,464 (5) | 1,814 (6) |
Total | 21,561 (360) | 8,923 (28) | 1,770 (5) | 32,254 (100) |
Concordance | 30,005 (93) | |||
One-risk factors | ||||
Low (<10%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Moderate (10–20%) | 1,325 (19) | 2,927 (41) | 170 (2) | 4,422 (62) |
High (>20%) | 0 (0) | 375 (5) | 2,310 (33) | 2,685 (38) |
Total | 1,325 (19) | 3,302 (46) | 2,480 (35) | 7,107 (100) |
Concordance | 5,237 (74) | |||
Two-risk factors | ||||
Low (<10%) | 0 (0) | 0 (0) | 4 (2) | 4 (2) |
Moderate (10–20%) | 0 (0) | 0 (0) | 55 (23) | 55 (23) |
High (>20%) | 0 (0) | 0 (0) | 183 (76) | 183 (76) |
Total | 0 (0) | 0 (0) | 242 (100) | 242 (100) |
Concordance | 183 (76) |
Results are stratified by the number of additional clinical risk factors (prior fragility fracture and prolonged glucocorticoid use)